Cystic Glucagonoma: A Rare Variant of an Uncommon Neuroendocrine Pancreas Tumor

被引:22
作者
Brown K. [1 ]
Kristopaitis T. [2 ]
Yong S. [2 ]
Chejfec G. [2 ]
Pickleman J. [1 ,3 ]
机构
[1] Department of Surgery, Loyola University Medical Center, Maywood, IL
[2] Department of Pathology, Loyola University Medical Center, Maywood, IL
[3] Department of Surgery, Loyola University Medical Center, Maywood, IL 60153
关键词
Cystic pancreatic neoplasm; Glucagonoma;
D O I
10.1016/S1091-255X(98)80053-X
中图分类号
学科分类号
摘要
Glucagon-producing neuroendocrine tumors typically present with a characteristic constellation of symptoms including necrolytic migratory erythema, non-insulin-dependent diabetes, weight loss, anemia, glossitis, and an increased thrombotic tendency. Most glucagonomas are solid and arise in the body or tail of the pancreas. We report two cases of cystic glucagonoma, one found incidentally in an asymptomatic patient and one in a patient with weight loss and diabetes but no rash. In the first patient, distal pancreatectomy and splenectomy were curative, whereas the second patient continued to exhibit elevated serum glucagon levels and symptoms of glucose intolerance in the absence of demonstrable metastases. Cystic glucagonoma is a unique variant of classic glucagonoma and should be considered in the differential diagnosis of cystic pancreatic neoplasms.
引用
收藏
页码:533 / 536
页数:3
相关论文
共 29 条
  • [1] McGavran M., Unger R., Recant L., Polk H., Kilo C., Levin M., A glucagon-secreting alpha-cell carcinoma of the pancreas, N Engl J Med, 274, pp. 1408-1413, (1966)
  • [2] Wilkinson D.S., Necrolytic migratory erythema with carcinoma of the pancreas, Trans St John's Hosp Dermatol Soc, 59, pp. 244-248, (1973)
  • [3] Higgins G., Recant L., Fischman A., The glucagonoma syndrome: Surgically curable diabetes, Am J Surg, 137, pp. 142-148, (1979)
  • [4] Haga Y., Yanagi H., Urata J., Inada M., Shimada S., Nitahata N., Early detection of pancreatic glucagonoma, Am J Gastroenterol, 90, pp. 2216-2221, (1995)
  • [5] Wynick D., Mattodn P.F., Bloom S.R., The glucagonoma syndrome, Clin Dermatol, 11, pp. 93-97, (1993)
  • [6] Sarui H., Yoshimoto K., Takuno H., Ishizuka T., Takao H., Shimokawa K., Cystic glucagonoma with loss of heterozygosity on chromosome 11 in multiple endocrine neoplasia type 1, Clin Endocrinol, 46, pp. 511-516, (1997)
  • [7] Ho P.W., Moore G.W., Hoge A.F., Glucagonoma occurring as a large cystic abdominal mass, South Med J, 77, (1984)
  • [8] Le Bodic M.F., Heymann M.F., Lecomte M., Berger N., Berger F., Louvel A., Immunohistochemical study of 100 pancreatic tumors in 28 patients with multiple endocrine neoplasia, type I, Am J Surg Pathol, 20, pp. 1378-1384, (1996)
  • [9] Davtyan H., Nieberg R., Reber H.A., Pancreatic cystic endocrine neoplasms, Pancreas, 5, pp. 230-233, (1990)
  • [10] Riddle M.C., Golper T.A., Fletcher W.S., Ensinck J.W., Smith P.H., Glucagonoma syndrome in a 19 year old woman, West J Med, 129, pp. 68-72, (1978)